Needham Reiterates Hold on Surmodics
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Hold rating on Surmodics (NASDAQ:SRDX).

August 05, 2024 | 5:51 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst Mike Matson has reiterated a Hold rating on Surmodics (NASDAQ:SRDX).
The reiteration of a Hold rating by Needham suggests that there are no significant changes in the analyst's outlook on Surmodics. This is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100